Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAn NIH-wide banner announces that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check34 days agoChange DetectedOn 2026-09-28 the study was terminated due to futility, and the record updates the Study Status and Recruitment Status accordingly, replacing the prior Completed entry.SummaryDifference0.3%

- Check48 days agoChange DetectedThe Record History page shows a new revision tag, updating from v3.6.6 to v3.7.0, indicating an updated version of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing the previous v3.6.5, indicating a new site release. This update does not alter the study details or records on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision tag on the Record History page updated from v3.6.4 to v3.6.5, indicating a new version of the site's software behind the history view. This change is an internal version bump rather than an update to study data or visible content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.